
Ozempic vs Mounjaro in Australia: Clinical Comparison, PBS Access, and What Pharmacists Need to Know
Semaglutide and tirzepatide are both effective for type 2 diabetes, but only Ozempic is PBS-subsidised in Australia. Mounjaro was rejected by PBAC in November 2024 and remains private-only at significant cost. Here's the full clinical and access comparison.


